Supply of Investigative Medicinal Product Dossier for Health Products Regulatory Authority

Description

Supply of Investigative Medicinal Product Dossier for Health Products Regulatory Authority trial conduct approval for investigation of 0.01% low dose atropine for the control of myopia in children. We are informed by the Irish Comptroller and Auditor General (C&AG) auditors that they require a VEAT to be published for unique providers/sole suppliers, and also for a four year cumulative period spending. They confirm they require VEAT publication of an award of a contract without prior publication of a call for competition in the Official Journal of the European Union. The cumulative amount in this instance is below the Directive threshold that would require publication in OJEU. It is therefore a non-OJEU service. National etenders platform does can facilitate publication of VEAT notices for non-OJEU notices that are under Directive threshold. The Irish C&AG auditors requires a VEAT to be published in this instance despite the non-applicability of the rules and the procurement falling outside the scope of application of the directive.